Swipe om te navigeren naar een ander artikel
In cancer research, outcome measures may co-vary. Treatment and treatment related impairment of health-related quality of life (HRQoL) may affect survival. When these effects are analyzed separately, bias may arise. Therefore, we investigated the combined effect of treatment and longitudinally measured HRQoL on survival.
Patients with anaplastic oligodendrogliomas (n = 288) who were randomized (EORTC 26951) to radiotherapy (RT) alone or RT plus procarbazine, lomustine, and vincristine (PCV) chemotherapy were analyzed. HRQoL [appetite loss (AP)] was assessed with the EORTC QLQ-C30. We compared survival results from different analysis strategies: Cox model with treatment only [model 1 (M1)] or with treatment and time-dependent AP score [model 2 (M2)] and the joint model combining longitudinal AP score and survival [model 3 (M3)].
The estimated hazard ratio (HR) for RT plus PCV was 0.76 (95 % CI 0.58–1.00) for M1, 0.72 (0.55–0.96) for M2, and 0.69 (0.52–0.92) for M3. This corresponds to a lower risk of death of 24 % in M1, 28 % in M2, and 31 % in M3, for patients treated with RT plus PCV chemotherapy. AP resulted in an increased risk of death, with estimated HR of 1.06 (1.01–1.12) for M2 and 1.13 (1.03–1.23) for M3: Every 10-point increase of AP resulted in a 13 % increased risk of death in M3 as compared to 6 % in M2.
Part of the survival benefit of treatment with RT plus PCV chemotherapy can be masked by the negative effect that this treatment has on patients’ HRQoL. In our study, up to 7 % of the theoretical treatment efficacy was lost when AP was not adjusted through joint modeling.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Eton, D. T., Fairclough, D. L., Cella, D., Yount, S. E., Bonomi, P., & Johnson, D. H. (2003). Early change in patient-reported health during lung cancer chemotherapy predicts clinical outcomes beyond those predicted by baseline report: Results from Eastern Cooperative Oncology Group Study 5592. Journal of Clinical Oncology, 21, 1536–1543. CrossRefPubMed
Wu, L., Liu, W., Yi, G. Y., & Huang, Y. (2012). Analysis of longitudinal and survival data: Joint modeling, inference methods, and issues. Journal of Probability and Statistics, 2012, 17. doi: 10.1155/2012/640153.
Rizopoulos, D. (2012). Joint models for longitudinal and time-to-event data: With applications in R. London: Chapman & Hall/CRC Biostatistics Series. CrossRef
Wu, M., & Caroll, R. (1988). Estimation and comparison of changes in the presence of informative right censoring by modelling the censoring process. Biometrics, 44, 175–188. CrossRef
Jacqmin-Gadda, H., Thiebaut, R., & Dartigues, J. F. (2004). Joint modeling of quantitative longitudinal data and censored survival time. RESP, 52, 502–510.
Thiebaut, R., Jacqmin-Gadda, H., Babiker, A., & Commenges, D. (2005). CASCADE collaboration. Joint modelling of bivariate longitudinal data with informative dropout and left-censoring, with application to the evolution of CD4+ cell count and HIV RNA viral load in response to treatment of HIV infection. Statistics in Medicine, 24, 65–82. CrossRefPubMed
Ye, W., Lin, X., & Taylor, J. (2008). Semiparametric modeling of longitudinal measurements and time-to-event data—a two stage regression calibration approach. Biometrics, 84, 1238–1246. CrossRef
DeGruttola, V., & Tu, X. M. (1994). Modeling progression of CD-4 lymphocyte count and its relationship to survival time. Biometrics, 50, 1003–1014. CrossRef
Little, R. J. A. (1995). Modeling the drop-out mechanism in repeated-measures studies. Journal of the American Statistical Association, 90, 1112–1121. CrossRef
Rizopoulos, D. (2010). JM: An R package for the joint modelling of longitudinal and time-to event data. Journal of Statistical Software, 35(9), 1–33.
Tsiatis, A. A., & Davidian, M. (2004). Joint modeling of longitudinal and time-to-event data: An overview. Statistica Sinica, 14, 809–834.
Tsiatis, A. A., DeGruttola, V., & Wulfsohn, M. S. (1995). Modeling the relationship of survival to longitudinal data measured with error. Applications to survival and CD4 counts in patients with AIDS. JASA, 90, 27–37. CrossRef
Little, R. J. A., & Rubin, D. B. (2002). Statistical analysis with missing data (2nd ed.). New York: Wiley. CrossRef
van den Bent, M. J., Brandes, A. A., Taphoorn, M. J. B., et al. (2013). Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: Long-term follow-up of EORTC brain tumor group study 26951. Journal of Clinical Oncology, 31, 344–350. CrossRefPubMed
Cull, A., Sprangers, M., Bjordal, K., et al. (2002). Guidelines for translating EORTC questionnaires. Brussels: Quality of Life Group Publications, EORTC Publications.
Osoba, D., Rodrigues, G., Myles, J., et al. (1998). Interpreting the significance of changes in health-related quality-of-life scores. Journal of Clinical Oncology, 16, 139–144. PubMed
de Boor, C. (2001). A practical guide to splines, vol. 27 of springer series in applied mathematics (2nd ed.). New York: Springer.
Taphoorn, M. J. B., van den Bent, M. J., Mauer, M. E., et al. (2007). Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: Results of a European Organisation for Research and Treatment of Cancer randomized clinical trial. Journal of Clinical Oncology, 25, 5723–5730. CrossRefPubMed
Schwarz, G. (1978). Estimating the dimension of a model. The Annals of Statistics, 6, 239–472. CrossRef
Viviani, S., Rizopoulos, D., & Alfo, M. (2014). Local sensitivity of shared parameter models to non-ignorability of dropout. Statistical Modelling, 14, 205–228.
R Core Team. (2013). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org/
SAS Institute Inc. (2011). SAS ® 9.3 system options: Reference (2nd ed.). Cary, NC: SAS Institute Inc.
Horowitz, J. L. (1999). Semiparametric estimation of a proportional hazard model with unobserved heterogeneity. Econometrica, 67, 1001–1028. CrossRef
Abbring, J. H., & Van den Berg, G. J. (2007). The unobserved heterogeneity distribution in duration analysis. Biometrika, 94, 87–99. CrossRef
Chen, L. M., Ibrahim, J. G., & Chu, H. (2011). Sample size and power determination in joint modeling of longitudinal and survival data. Statistics in Medicine, 2011(30), 2295–2309. CrossRef
Rizopoulos, D., Murawska, M., Andrinopoulou, E. R., Molenberghs, G., Takkenberg, J. J. M., & Lesaffre, E. (2013). Dynamic predictions with time-dependent covariates in survival analysis using joint modeling and land marking. arXiv:1306.6479v1.
- Joint modeling of longitudinal health-related quality of life data and survival
Divine E. Ediebah
Bernard M. J. Uitdehaag
Jaap C. Reijneveld
Martin J. van den Bent
Martin J. B. Taphoorn
- Springer International Publishing